-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$79.0042.63% Upside
ANI Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. has been rated by research analysts at Raymond James, Truist Financial, H.C. Wainwright in the past 90 days.